STERIALS

A clinical stage biopharmaceutical company focused on developing cancer treatments. The company is developing novel oncolytic adenovirus products for intravenous and intraorbital administration, and is developing treatments for pancreatic cancer and retinoblastoma that degrade the tumor stromal barrier, which is an important immunosuppressive barrier in cancer treatment. The company is also developing treatments for gastrointestinal disorders. The company is based in Nevada.